Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Translational Oncology
|
September 7, 2025
Clinical applications of cell-free DNA-based liquid biopsy analysis
Shu Yazaki, Momoko Tokura, Hisaki Aiba, et al.
Cells
|
September 28, 2023
Investigation of Tumor Heterogeneity Using Integrated Single-Cell RNA Sequence Analysis to Focus on Genes Related to Breast Cancer-, EMT-, CSC-, and Metastasis-Related Markers in Patients with HER2-Positive Breast Cancer
Sho Shiino, Momoko Tokura, Jun Nakayama, et al.
Endocrine Journal
|
December 12, 2017
Parathyroid carcinoma occurred in two glands in multiple endocrine neoplasia 1: a report on a rare case
Yoko Omi, Kiyomi Horiuchi, Kento Haniu, et al.
Cancer Science
|
May 21, 2026
Spatial Transcriptomics and Bulk RNA-Seq Analysis Revealed Molecular Classification of Invasive Lobular Carcinoma
Momoko Tokura, Jun Nakayama, Hironori Suzuki, et al.
International Journal of Surgery Case Reports
|
March 21, 2020
Locally advanced triple negative breast cancer arising from fibroadenoma with complete response to neoadjuvant chemotherapy: A case report
Sho Shiino, Masayuki Yoshida, Momoko Tokura, et al.
Cancer Research
|
July 19, 2022
Single-Cell Transcriptome Profiling Reveals Intratumoral Heterogeneity and Molecular Features of Ductal Carcinoma In Situ
Momoko Tokura, Jun Nakayama, Marta Prieto-Vila, et al.
BMC Cancer
|
April 15, 2022
Diagnostic value of tumor markers in identifying favorable or unfavorable subsets in patients with cancer of unknown primary: a retrospective study
Shigemasa Takamizawa, Tatsunori Shimoi, Masayuki Yoshida, et al.
Scientific Reports
|
July 3, 2023
Lymphocyte-to-monocyte ratio as a prognostic and potential tumor microenvironment indicator in advanced soft tissue sarcoma treated with first-line doxorubicin therapy
Sho Watanabe, Tatsunori Shimoi, Tadaaki Nishikawa, et al.
Cancer Cell International
|
February 4, 2023
Changes in HER3 expression profiles between primary and recurrent gynecological cancers
Yuki Kojima, Kazuki Sudo, Hiroshi Yoshida, et al.
Frontiers in Oncology
|
April 13, 2023
Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancer
Tomomi Sanomachi, Hitomi Sumiyoshi Okuma, Rui Kitadai, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Translational Oncology
|
September 7, 2025
Clinical applications of cell-free DNA-based liquid biopsy analysis
Shu Yazaki, Momoko Tokura, Hisaki Aiba, et al.
Cells
|
September 28, 2023
Investigation of Tumor Heterogeneity Using Integrated Single-Cell RNA Sequence Analysis to Focus on Genes Related to Breast Cancer-, EMT-, CSC-, and Metastasis-Related Markers in Patients with HER2-Positive Breast Cancer
Sho Shiino, Momoko Tokura, Jun Nakayama, et al.
Endocrine Journal
|
December 12, 2017
Parathyroid carcinoma occurred in two glands in multiple endocrine neoplasia 1: a report on a rare case
Yoko Omi, Kiyomi Horiuchi, Kento Haniu, et al.
Cancer Science
|
May 21, 2026
Spatial Transcriptomics and Bulk RNA-Seq Analysis Revealed Molecular Classification of Invasive Lobular Carcinoma
Momoko Tokura, Jun Nakayama, Hironori Suzuki, et al.
International Journal of Surgery Case Reports
|
March 21, 2020
Locally advanced triple negative breast cancer arising from fibroadenoma with complete response to neoadjuvant chemotherapy: A case report
Sho Shiino, Masayuki Yoshida, Momoko Tokura, et al.
Cancer Research
|
July 19, 2022
Single-Cell Transcriptome Profiling Reveals Intratumoral Heterogeneity and Molecular Features of Ductal Carcinoma In Situ
Momoko Tokura, Jun Nakayama, Marta Prieto-Vila, et al.
BMC Cancer
|
April 15, 2022
Diagnostic value of tumor markers in identifying favorable or unfavorable subsets in patients with cancer of unknown primary: a retrospective study
Shigemasa Takamizawa, Tatsunori Shimoi, Masayuki Yoshida, et al.
Scientific Reports
|
July 3, 2023
Lymphocyte-to-monocyte ratio as a prognostic and potential tumor microenvironment indicator in advanced soft tissue sarcoma treated with first-line doxorubicin therapy
Sho Watanabe, Tatsunori Shimoi, Tadaaki Nishikawa, et al.
Cancer Cell International
|
February 4, 2023
Changes in HER3 expression profiles between primary and recurrent gynecological cancers
Yuki Kojima, Kazuki Sudo, Hiroshi Yoshida, et al.
Frontiers in Oncology
|
April 13, 2023
Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancer
Tomomi Sanomachi, Hitomi Sumiyoshi Okuma, Rui Kitadai, et al.
Page
of 2